Protective efficacy of the inactivated H5N1 influenza vaccine Re-6 against different clades of H5N1 viruses isolated in China and the democratic people's republic of korea

Avian Diseases

Volumn 60, Issue 1, 2016, Pages 238-240

  Zeng, Xianying ^a   Deng, Guohua ^a   Liu, Liling ^a   Li, Yanbing ^a   Shi, Jianzhong ^a   Chen, Pucheng ^a   Feng, Huapeng ^a   Liu, Jingli ^b   Guo, Xingfu ^b   Mao, Shenggang ^b   Yang, Fan ^b   Chen, Zhiyu ^b   Tian, Guobin ^a   Chen, Hualan ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b Weike Biotechnology Development Company   (China)

Author keywords

Avian influenza; H5N1 subtype; Inactivated vaccine; Protective efficacy

Indexed keywords

INFLUENZA VACCINE;

ANIMAL; CHICKEN; CHINA; CLASSIFICATION; DUCK; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H5N1); INFLUENZA IN BIRDS; NORTH KOREA; PHYSIOLOGY; POULTRY DISEASES; VIROLOGY; VIRUS SHEDDING;

ANIMALS; CHICKENS; CHINA; DEMOCRATIC PEOPLE'S REPUBLIC OF KOREA; DUCKS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY DISEASES; VIRUS SHEDDING;

EID: 84987754262     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/11178-051915-ResNote     Document Type: Conference Paper

References (10)

1. Li, C., Z. Bu, and H. Chen. Avian influenza vaccines against H5N1 'bird flu'. Trends Biotechnol. 32:147-156. 2014.
2. Li, Y., J. Shi, G. Zhong, G. Deng, G. Tian, J. Ge, X. Zeng, J. Song, D. Zhao, L. Liu, Y. Jiang, Y. Guan, Z. Bu, and H. Chen. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. J. Virol. 84:8389-8397. 2010.
3. Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305:192-200. 2003.
4. Swayne, D. E. Impact of vaccines and vaccination on global control of avian influenza. Avian Dis. 56:818-828. 2012.
5. Swayne, D. E., E. Spackman, and M. Pantin-Jackwood. Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-Agricultural interface. EcoHealth 11:94-108. 2014.
6. Tian, G., X. Zeng, Y. Li, J. Shi, and H. Chen. Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam. Avian Dis. 54:287-289. 2010.
7. [WHO] World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. 2015 [modified 2015 Feb 26; cited 2015 Apr 3]. Available from: http://www.who.int/influenza/vaccines/virus/201502-zoonotic-vaccinevirusupdate.pdf?ua=1.2015.
8. [WHO/OIE/FAO H5N1 Evolution Working Group] World Health Organization, World Organisation for Animal Health, Food and Agriculture Organization of the United Nations H5N1 Evolution Working Group. Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respir. Viruses 6:1-5. 2012.
9. WHO/OIE/FAO H5N1 Evolution Working Group. Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza Other Respir. Viruses 8:384-388. 2014.
10. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza. Update on avian influenza A (H5N1) virus infection in humans. N. Engl. J. Med. 358:261-273. 2008.